FIELD: medicine.
SUBSTANCE: invention is intended to determine the pressure in tumours, which can be used to optimize the regimens of chemotherapy aimed at increased effectiveness of treatment, selection of a therapeutic agent or a combination thereof, adjusted dosage of the prescribed drugs, and optimised time of administration during the day. The mean radius of the tumour (ΔL) is measured, control drug represented by magneto-contrast nanoparticles are introduced in the tumor at a concentration sufficient for detection using MRI. Then, the MR signal is measured during control drug removal from the tumour, and the dependence of the change in the MR signal intensity in the tumour on time is plotted. Next, the target drug is introduced into the tumour, which is nanoparticles used in the control drug, covalently crosslinked with a protein with lectin properties, after the time necessary to remove the control drug from the body. Then, the MR signal is measured during target drug removal from the tumour, and the dependence of the change in the MR signal intensity in the tumour on time is plotted. The obtained dependences determine the delay time Δt of the target drug removal from the tumour relative to the control drug with subsequent calculation of the tumour pressure according to the appropriate formula.
EFFECT: method provides an objective and non-invasive pressure measurement in the tumour, including several tumour sites.
8 cl, 1 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR OBTAINING A VEGETABLE ML1 LECTURE FROM A MISSILE WHITE AND A PHARMACEUTICAL COMPOSITION ON ITS BASIS (VARIANTS) | 2016 |
|
RU2644332C1 |
NANOMATERIAL FOR TARGETED DELIVERY OF ANTICANCER AGENTS AND ANTICANCER AGENTS BASED ON IT | 2016 |
|
RU2610170C1 |
NANOCOMPOSITES BASED ON GADOLINIUM-CONTAINING COMPOUNDS FOR DIAGNOSIS, THERAPY, AND THERANOSTICS OF ONCOLOGICAL DISEASES OF THE BRAIN AND METHODS FOR PRODUCTION THEREOF | 2021 |
|
RU2778928C1 |
CONJUGATE OF NANOPARTICLES OF GOLD-MAGNETITE COMPOSITION WITH FUNCTIONAL MOLECULE (OPTIONS) AND METHOD OF USE (OPTIONS) | 2023 |
|
RU2811020C1 |
STEM CELL PREPARATION WITH REPROGRAMMED CELL SIGNALLING, METHOD FOR MAKING THIS PREPARATION AND APPLICATION THEREOF | 2008 |
|
RU2428475C2 |
SUBSTANCE AND METHOD FOR MODULATION OF ACTIVITY OF AGENT IN BODY | 2014 |
|
RU2683020C2 |
APPLICATION OF 1,3-BIS(PERFLUORO-TERT-BUTYL)PROPANE AS A CONTRAST AGENT FOR MAGNETIC RESONANCE IMAGING ON F NUCLEI | 2022 |
|
RU2785791C1 |
1,2-BIS(PERFLUORO-tert-BUTOXY)ETHANE AS A CONTRAST FOR F NUCLEUS MAGNETIC RESONANCE IMAGING | 2022 |
|
RU2795915C1 |
HEPATO-TROPIC MAGNETIC RESONANCE DEVICE | 2014 |
|
RU2577298C1 |
DIAGNOSTIC TECHNIQUE FOR GLIOBLASTOMA MULTIFORME BY MAGNETIC RESONANCE TOMOGRAPHY | 2012 |
|
RU2530762C2 |
Authors
Dates
2017-10-06—Published
2016-12-30—Filed